Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Using index funds for stock diversification can simplify your investment strategy. Explore how they can provide broad market exposure.
23,126 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Backlogs can power stock moves, but they also raise questions about execution, risk, and long-term profitability. Thi...
Optex Systems faces a pivotal Q2 2026, balancing defense demand with supply chain shifts. This analysis breaks down t...
Nvidia and Broadcom lead the AI chip market, but which one deserves a place in a modern portfolio? This guide breaks ...
As chip stocks wobble, there are three AI-focused names that still stand out to me. This guide explains why they matt...
CECO (CECO) 2025 earnings will hinge on project backlogs, margins, and demand for air quality and energy solutions. T...
In 2026, two names inside the Magnificent Seven could deliver outsized AI gains that fly under the radar. This guide ...
A leading CIO cautions that AI stock valuations may be stretched beyond sustainable growth. The article surveys what ...
When a CEO with Nvidia’s clout announces a partner could be the next trillion-dollar company, investors listen. This ...
Intel has been sliding over the last month. One analyst argues the company could double its value as its foundry busi...
A trio of blue-chip dividend payers is delivering double-digit gains and reliable income for retirees as 2026 unfolds...
A seven-name AI hardware rally is reshaping bets for 2026, with Parabolic 7 outpacing the Magnificent 7 and drawing n...